Article

Online risk calculator will guide in management of ocular hypertension

Online risk calculator will guide in management of ocular hypertension

Based on data from the Ocular Hypertension Treatment Study (OHTS), researchers have identified five risk factors that can be used to predict which patients with ocular hypertension will develop open-angle glaucoma. From this data they have developed a risk calculator that should be available online soon, according to Michael A. Kass, MD, professor and chairman of ophthalmology and visual sciences at the Washington University School of Medicine, St. Louis.

"We know that lowering IOP will decrease the incidence of glaucoma by more than 50%," Dr. Kass said. "However, we don't treat all patients with elevated pressure. We manage them with risk stratification."

He spoke to the media during the American Academy of Ophthalmology annual meeting.

The five risk factors for glaucoma in patients with ocular hypertension are:

  • Increased IOP.


  • Older age.


  • Thinner central corneal thickness.


  • Increased cup-to-disc ratio.


  • Increased PSD on a Humphrey visual field test.

"This predictive calculator will be available on the Web and will help determine low-risk and high-risk patients," said Dr. Kass, who was the principal investigator and study chairman of the OHTS, sponsored by the National Institutes of Health.

"The patient benefit will be that those who most need treatment will receive it," he said. "It will likely decrease the number of patients on medications."

Other glaucoma experts covered diagnostic tools; glaucoma treatments, such as SLT versus medications and glaucoma filtering surgery; sleep apnea and glaucoma; and driving and peripheral vision loss.

Donald L. Budenz, MD, MPH, professor of ophthalmology, epidemiology, and public health at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, moderated the session.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.